Subjects: Drug Approval -- economics - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Drug Approval -- economics

1. Prescription Drug User Fee Act waivers, reductions, and refunds for drug and biological products

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, October 2019
Subject(s):: Drug Approval -- economics
Drug Approval -- legislation & jurisprudence
Investigational New Drug Application -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

2. Strengthening the accelerated approval pathway: an analysis of potential policy reforms and their impact on uncertainty, access, innovation, and costs

Author(s):: Kaltenboeck, Anna, author
Mehlman, Amanda, author
Pearson, Steven D., author
Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 26, 2021
Subject(s):: Drug Approval -- economics
Drug Approval -- legislation & jurisprudence
United States

3. Economic analysis of availability of follow-on protein products: final report

Publication:: [Washington, DC] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2009
Subject(s):: Proteins -- economics
Biological Products
Drug Approval -- economics
United States